The purpose of this study was therefore to demonstrate that doubling the dose of Seretide™ administered via a Diskus™ inhaler in subjects with varying degrees of asthma is safe and well ...

However, Seretide is available both as a pMDI and in the Diskus dry powder inhaler, and is also approved for patients with chronic obstructive pulmonary disease (COPD) as well as asthma in ...

During the run-in, all subjects were required to stop their inhaled corticosteroid and long-acting β 2-agonist if appropriate and take Seretide™ one inhalation twice daily from a Diskus ...

Consider the example from the US of GlaxoSmithKline’s Advair (seretide) formulation, which came off patent in 2010 [although integration as part of the Diskus delivery device extended the patent ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.